Materialise NV (NASDAQ: MTLS), a leading provider of additive
manufacturing software and of sophisticated 3D printing services,
today announced its financial results for the first quarter ended
March 31, 2017.
Highlights – First Quarter 2017
- Total revenue increased 19.7% from the
first quarter of 2016 to 31,921 kEUR, with double-digit increases
in all three business segments.
- Total deferred revenue from annual
software sales and maintenance contracts increased by 1,285 kEUR
from December 31, 2016 to 18,084 kEUR at the end of the first
quarter.
- Adjusted EBITDA rose from 1,135 kEUR
for the first quarter of 2016 to 2,813 kEUR.
Executive Chairman Peter Leys commented, “The year is off to an
excellent start for Materialise. Amid signs that the overall demand
environment for additive manufacturing (“AM”) is strengthening, we
delivered double-digit growth in all our business segments and more
than doubled Adjusted EBITDA. We are particularly encouraged by the
wide range of industries that are tapping into the Materialise
backbone in a variety of ways to realize meaningful applications of
AM. During the quarter, we pushed ahead with our partnerships to
prepare for the launch of Yuniku, the world’s first vision-centric
3D-tailored eyewear, and to integrate functionalities of
Materialise Magics into product lifecycle management tools,
streamlining the design-to-manufacturing process for the growing
universe of products being produced using AM.”
First Quarter 2017 Results
Total revenue for the first quarter of 2017 increased 19.7% to
31,921 kEUR compared to 26,667 kEUR for the first quarter
of 2016, with gains in all three of our segments, particularly
Materialise Manufacturing. Adjusted EBITDA increased to
2,813 kEUR from 1,135 kEUR as a result of the combination
of continued revenue growth (19.7%) and a significantly lower
increase in operational expenses (7.4%) as compared to the first
quarter in 2016. The Adjusted EBITDA margin (Adjusted EBITDA
divided by total revenue) in the first quarter was 8.8% compared to
4.3% in the first quarter of 2016.
Revenue from our Materialise Software segment, which offers a
proprietary software backbone that enables and enhances the
functionality of 3D printers and 3D printing operations worldwide,
increased 15.4% to 8,575 kEUR for the first quarter of 2017 from
7,431 kEUR for the same quarter last year. Recurrent revenues
from annual and renewed licenses and maintenance fees grew 22.3%
from the same period in the prior year. Segment EBITDA rose to
2,993 kEUR from 2,765 kEUR while the segment EBITDA
margin was 34.9% compared to 37.2% in the prior-year period.
Revenue from our Materialise Medical segment, which offers a
unique platform consisting of medical planning and design software,
clinical engineering services and patient specific devices,
increased 15.4% to 9,932 kEUR for the first quarter of 2017
compared to 8,606 kEUR for the same period in 2016. Compared
to the same quarter in 2016, revenues from our medical software
grew 16.0%, and revenues from our collaborated medical device
business and from direct sales of complex surgery solutions each
grew 15.0%. Segment EBITDA was 314 kEUR compared to
(530) kEUR while the segment EBITDA margin increased to 3.2%
from (6.2)% in the first quarter of 2016.
Revenue from our Materialise Manufacturing segment, which offers
an integrated suite of 3D printing and engineering services to
industrial and commercial customers, increased 26.4% to
13,407 kEUR for the first quarter of 2017 from
10,606 kEUR for the first quarter of 2016. End part
manufacturing revenues increased 35.0% compared to the first
quarter of 2016. Segment EBITDA rose to 1,322 kEUR from
257 kEUR while the segment EBITDA margin increased to 9.9%
from 2.4% for the same quarter in 2016.
Gross profit was 18,477 kEUR, or 57.9 % of total
revenue, for the first quarter of 2017 compared to
15,962 kEUR, or 59.9 % of total revenue, for the first
quarter of 2016. The decrease in the gross profit margin was
primarily a result of increased production of medical devices and
implants, involving higher cost of production.
Research and development (“R&D”), sales and marketing
(“S&M”) and general and administrative (“G&A”) expenses
increased, in the aggregate, 7.4% to 19,579 kEUR for the first
quarter of 2017 from 18,237 kEUR for the first quarter of
2016. R&D expenses increased from 4,372 kEUR to
4,592 kEUR while S&M expenses increased from
8,815 kEUR to 9,608 kEUR. G&A expenses increased from
5,050 kEUR to 5,379 kEUR.
Net other operating income decreased by (268) kEUR to
1,018 kEUR compared to 1,286 kEUR for the first quarter
of 2016. Net other operating income consists primarily of
withholding tax exemptions for qualifying researchers, development
grants, partial funding of R&D projects and currency exchange
results on purchase and sales transactions.
Operating loss improved to (84) kEUR from (989) kEUR
for the same period in the prior year. This improvement was the
result of a combination of an increase in gross profit of 15.8% and
an increase of only 7.4% in R&D, S&M and G&A expenses,
which were partially offset by a slight decrease of (268) kEUR
of net other operating income compared to the same quarter in
2016.
Net financial result was (142) kEUR compared to
(734) kEUR for the prior-year period, reflecting smaller
variances in the currency exchange rates, primarily on the portion
of the company’s IPO proceeds held in U.S. dollars versus the
euro.
Net loss for the first quarter of 2017 was (816) kEUR
compared to net loss of (3,151) kEUR for the same period in
2016. The 2016 period contained income tax expense of
1,260 kEUR primarily from deferred taxes compared to income
tax expense of 201 kEUR this quarter. The decrease in the net
loss for the first quarter of 2017 was primarily attributable to
this variance of 1,059 kEUR in income tax, as well as an
increase in the financial result of 592 kEUR and the decrease
in operating loss by 905 kEUR, which were partially offset by
an increase of 221 kEUR in the share in the loss of a joint
venture. Total comprehensive loss for the first quarter of 2017,
which includes exchange differences on translation of foreign
operations, was 694 kEUR compared to 4,115 kEUR for the
same period in 2016.
At March 31, 2017, we had cash and equivalents of 55,071 kEUR
compared to 55,912 kEUR at December 31, 2016. Cash flow from
operating activities in the first quarter of 2017 was 1,603 kEUR
compared to 1,376 kEUR in the same period in 2016.
Net shareholders’ equity at March 31, 2017 was 78,585 kEUR
compared to 79,033 kEUR at December 31, 2016.
2017 Guidance
As detailed in the company’s year-end fiscal 2016 earnings
announcement, in fiscal 2017 management expects to report
consolidated revenue between 128,000 - 134,000 kEUR and Adjusted
EBITDA between 10,500 – 13,500 kEUR. Management also expects the
amount of deferred revenue the company generates from annual
licenses and maintenance in 2017 to increase by an amount between
4,000 - 5,000 kEUR as compared to 2016.
Non-IFRS Measures
Materialise uses EBITDA and Adjusted EBITDA as supplemental
financial measures of its financial performance. EBITDA is
calculated as net profit plus income taxes, financial expenses
(less financial income), shares of loss in a joint venture and
depreciation and amortization. Adjusted EBITDA is determined by
adding non-cash stock-based compensation expenses to EBITDA.
Management believes these non-IFRS measures to be important
measures as they exclude the effects of items that primarily
reflect the impact of long-term investment and financing decisions,
rather than the performance of the company's day-to-day operations.
As compared to net profit, these measures are limited in that they
do not reflect the periodic costs of certain capitalized tangible
and intangible assets used in generating revenues in the company's
business, or the charges associated with impairments. Management
evaluates such items through other financial measures such as
capital expenditures and cash flow provided by operating
activities. The company believes that these measurements are useful
to measure a company's ability to grow or as a valuation
measurement. The company's calculation of EBITDA and Adjusted
EBITDA may not be comparable to similarly titled measures reported
by other companies. EBITDA and Adjusted EBITDA should not be
considered as alternatives to net profit or any other performance
measure derived in accordance with IFRS. The company's presentation
of EBITDA and Adjusted EBITDA should not be construed to imply that
its future results will be unaffected by unusual or non-recurring
items.
Exchange Rate
This press release contains translations of certain euro amounts
into U.S. dollars at specified rates solely for the convenience of
readers. Unless otherwise noted, all translations from euros to
U.S. dollars in this press release were made at a rate of EUR 1.00
to USD 1.0691, the reference rate of the European Central Bank on
March 31, 2017.
Conference Call and Webcast
Materialise will hold a conference call and simultaneous webcast
to discuss its financial results for the first quarter of 2017
today, May 9, 2017, at 8:30 a.m. ET/14:30 CET. Company participants
on the call will include Wilfried Vancraen, Founder and Chief
Executive Officer; Peter Leys, Executive Chairman; and Johan
Albrecht, Chief Financial Officer. A question-and-answer session
will follow management’s remarks.
To access the conference call, please dial 844-469-2530 (U.S.)
or 765-507-2679 (international), passcode #8533089. The conference
call will also be broadcast live over the Internet with an
accompanying slide presentation, which can be accessed on the
company’s website at http://investors.materialise.com.
A replay of the conference call will be available via telephone
beginning approximately two hours after the call ends through
Wednesday, May 10, 2017. U.S. participants can access the replay by
dialing 855-859-2056 and international participants can dial
404-537-3406. The access code for the replay is #8533089. A webcast
of the conference call and slide presentation will be archived on
the company's website for one year.
About Materialise
Materialise incorporates more than 25 years of 3D printing
experience into a range of software solutions and 3D printing
services, through which Materialise seeks to form the backbone of
the 3D printing industry. Materialise’s open and flexible solutions
enable players in a wide variety of industries, including
healthcare, automotive, aerospace, art and design, and consumer
goods, to build innovative 3D printing applications that aim to
make the world a better and healthier place. Headquartered in
Belgium, with branches worldwide, Materialise combines one of the
largest groups of software developers in the industry with one of
the largest 3D printing facilities in the world. For additional
information, please visit: www.materialise.com.
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, regarding, among other things, our intentions, beliefs,
assumptions, projections, outlook, analyses or current
expectations, plans, objectives, strategies and prospects, both
financial and business, including statements concerning, among
other things, current estimates of fiscal 2017 revenues, deferred
revenue from annual licenses and maintenance and Adjusted EBITDA,
results of operations, cash needs, capital expenditures, expenses,
financial condition, liquidity, prospects, growth and strategies,
and the trends and competition that may affect the markets,
industry or us. Such statements are subject to known and unknown
uncertainties and risks. When used in this press release, the words
“estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,”
“believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,”
“should,” and variations of such words or similar expressions are
intended to identify forward-looking statements. These
forward-looking statements are based upon the expectations of
management under current assumptions at the time of this press
release. These expectations, beliefs and projections are expressed
in good faith and the company believes there is a reasonable basis
for them. However, the company cannot offer any assurance that our
expectations, beliefs and projections will actually be achieved. By
their nature, forward-looking statements involve risks and
uncertainties because they relate to events, competitive dynamics
and industry change, and depend on economic circumstances that may
or may not occur in the future or may occur on longer or shorter
timelines than anticipated. We caution you that forward-looking
statements are not guarantees of future performance and involve
known and unknown risks, uncertainties and other factors that are
in some cases beyond our control. All of the forward-looking
statements are subject to risks and uncertainties that may cause
the company's actual results to differ materially from our
expectations, including risk factors described in the company's
annual report on Form 20-F filed with the U.S. Securities and
Exchange Commission on May 1, 2017. There are a number of risks and
uncertainties that could cause the company's actual results to
differ materially from the forward-looking statements contained in
this press release.
The company is providing this information as of the date of this
press release and does not undertake any obligation to update any
forward-looking statements contained in this press release as a
result of new information, future events or otherwise, unless it
has obligations under the federal securities laws to update and
disclose material developments related to previously disclosed
information.
Consolidated income statement
(Unaudited)
For the three months ended 31 March (in thousands,
except per share amounts)
2017 2017
2016 U.S.$ € € Revenue 34,127
31,921 26,667 Cost of sales (14,373) (13,444) (10,705)
Gross
profit 19,754 18,477 15,962 Gross profit
as % of revenue 58% 58% 60% Research and development
expenses (4,909) (4,592) (4,372) Sales and marketing expenses
(10,272) (9,608) (8,815) General and administrative expenses
(5,751) (5,379) (5,050) Net other operating income (expenses) 1,088
1,018 1,286
Operating (loss) profit (90) (84)
(989) Financial expenses (983) (919) (897) Financial
income 831 777 163 Share in loss of joint venture (416) (389) (168)
(Loss) profit before taxes (658) (615)
(1,891) Income taxes (215) (201) (1,260)
Net
(loss) profit of the period (873) (816)
(3,151) Net (loss) profit attributable to: The owners of the
parent (873) (816) (3,151) Non-controlling interest − − −
Earnings per share attributable to ordinary owners of the
parent Basic (0.02) (0.02) (0.07) Diluted (0.02) (0.02) (0.07)
Weighted average basic shares outstanding 47,325 47,325
47,325 Weighted average diluted shares outstanding 47,325 47,325
47,325
Consolidated statements of
comprehensive income (Unaudited)
For the three months ended 31 March (in thousands)
2017 2017 2016 U.S.$
€ € Net profit (loss) for the period
(873) (816) (3,151) Other comprehensive income
Exchange difference on translation of foreign operations 130
122 (964) Other comprehensive income (loss), net of
taxes 130 122 (964)
Total comprehensive income (loss) for the
period, net of taxes (743) (694) (4,115)
Total comprehensive income (loss) attributable to: The owners of
the parent (743) (694) (4,115) Non-controlling interest − − −
Consolidated statement of financial
position (Unaudited)
As of March 31
As ofDecember 31
(in thousands)
2017 2016 € €
Assets
Non-current assets
Goodwill 8,897 8,860 Intangible assets 9,468 9,765 Property, plant
& equipment 52,238 45,063 Investments in joint ventures 111 −
Deferred tax assets 276 336 Other non-current assets 2,309 2,154
Total non-current assets
73,299 66,178
Current assets
Inventories 8,267 7,870 Trade receivables 30,507 27,479 Held to
maturity investments − − Other current assets 4,691 4,481 Cash and
cash equivalents 55,071 55,912
Total current assets
98,536 95,742 Total assets 171,835
161,920
Equity and liabilities Equity
Share capital
2,729 2,729
Share premium
79,263 79,019
Consolidated reserves
(2,417) (1,603)
Other comprehensive income
(990) (1,112)
Equity attributable to the owners of
the parent
78,585 79,033 Non-controlling interest − −
Total equity
78,585 79,033
Non-current liabilities
Loans & borrowings
34,982 28,267 Deferred tax liabilities 1,256 1,325 Deferred income
3,942 3,588 Other non-current liabilities 2,026 1,873
Total
non-current liabilities 42,206 35,053
Current liabilities
Loans & borrowings 6,426 5,539 Trade payables 13,743 13,400 Tax
payables 874 926 Deferred income 19,607 17,822 Other current
liabilities 10,394 10,147
Total current liabilities
51,044 47,834 Total equity and liabilities
171,835 161,920
Consolidated statement of cash flows
(Unaudited)
For the three months endedMarch
31
(in thousands)
2017 2016 € €
Operating activities Net (loss) profit of the period (816)
(3,151) Non-cash and operational adjustments Depreciation of
property, plant & equipment 1,945 1,448 Amortization of
intangible assets 623 462 Share-based payment expense 329 214 Loss
(gain) on disposal of property, plant & equipment (2) −
Movement in provisions 4 − Movement reserve for bad debt 122 42
Financial income (136) (48) Financial expense 359 254 Impact of
foreign currencies (81) 528 Share in loss of a joint venture
(equity method) 389 168 Deferred tax expense (income) 1 868 Income
taxes 203 358 Other (72) −
Working capital adjustment &
income tax paid Increase in trade receivables and other
receivables (3,452) (285) Decrease (increase) in inventories (406)
215 Increase in trade payables and other payables 2,729 421 Income
tax paid (136) (118)
Net cash flow from operating activities
1,603 1,376
Investing activities Purchase of property, plant &
equipment (7,507) (1,325) Purchase of intangible assets (327) (265)
Proceeds from the sale of property, plant & equipment (net) 70
85 Investments in joint-ventures (500) − Interest received 108 3
Net cash flow used in investing activities (8,156)
(1,502)
Financing activities
Proceeds from loans & borrowings 7,710 604 Repayment of loans
& borrowings (756) (656) Repayment of finance leases (728)
(419) Interest paid (152) (141) Other financial income (expense)
(166) (33)
Net cash flow from (used in) financing activities
5,908 (645) Net increase of cash & cash
equivalents (645) (771) Cash & cash
equivalents at beginning of the period 55,912 50,726 Exchange rate
differences on cash & cash equivalents (196) (520)
Cash
& cash equivalents at end of the period 55,071
49,435
Reconciliation of Net Profit (Loss) to
EBITDA and Adjusted EBITDA (Unaudited)
For the three monthsended 31
March
(in thousands)
2017 2016 € €
Net profit (loss) for the period (816)
(3,151) Income taxes
201 1,260 Finance
expenses 919 897 Finance income
(777) (163) Share in
loss of joint venture 389 168 Depreciation and amortization
2,568 1,910 EBITDA 2,484
921 Non-cash stock-based compensation expense (1) 329
214
ADJUSTED EBITDA 2,813 1,135 (1)
Non-cash stock-based compensation expenses represent the
cost of equity-settled and cash-settled share-based payments to
employees.
Segment P&L (Unaudited)
(in thousands)
MaterialiseSoftware
MaterialiseMedical
MaterialiseManufact-uring
Totalsegments
Unallocated
Consoli-dated
€ € € € € € For
the three months ended March 31, 2017 Revenues 8,575 9,932
13,407 31,914 8 31,922 Segment EBITDA 2,993 314 1,322 4,629 (2,145)
2,484
Segment EBITDA %
34.9% 3.2% 9.9% 14.5% 7.8%
For the three months ended
March 31, 2016 Revenues 7,431 8,606 10,606 26,643 24 26,667
Segment EBITDA 2,765 (530) 257 2,492 (1,571) 921
Segment EBITDA %
37.2% -6.2% 2.4% 9.4% 3.5%
Reconciliation of Net Profit (Loss) to
Segment EBITDA (Unaudited)
For the three monthsended 31
March
(in thousands)
2017 2016 € €
Net profit (loss) for the period (816)
(3,151) Income taxes 201 1,260 Finance cost 919 897 Finance
income (777) (163) Share in loss of joint venture
389
168 − −
Operating profit (84) (989)
Depreciation and amortization 2,568 1,910 Corporate research
and development 509 567 Corporate headquarter costs 2,073 1,738
Other operating income (expense) (437) (734)
Segment
EBITDA 4,629 2,492
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170509005233/en/
Investor:LHAHarriet Fried/Jody
Burfening212-838-3777hfried@lhai.com
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Materialise NV (NASDAQ:MTLS)
Historical Stock Chart
From Apr 2023 to Apr 2024